Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sona Nanotech Inc (SONA.CN)

Sona Nanotech Inc (SONA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 57,633
  • Shares Outstanding, K 113,005
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,704 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.76
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 171.83

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4700 +6.38%
on 11/24/25
0.6200 -19.35%
on 11/10/25
-0.0800 (-13.79%)
since 11/05/25
3-Month
0.4700 +6.38%
on 11/24/25
0.8400 -40.48%
on 10/20/25
-0.1100 (-18.03%)
since 09/05/25
52-Week
0.2400 +108.33%
on 12/30/24
0.9100 -45.05%
on 07/16/25
+0.2300 (+85.19%)
since 12/05/24

Most Recent Stories

More News
First Patient Dosed in Early Feasibility Study Trial of its Cancer Therapy

Trial is expected to provide key insights on safety, tolerability and immune system response for its THT treatment of late-stage melanoma patientsHalifax, Nova Scotia--(Newsfile Corp. - July 7, 2025) -...

SONA.CN : 0.5000 (unch)
Sona Announces Ethics Committee Approval For Melanoma Clinical Trial

Halifax, Nova Scotia--(Newsfile Corp. - June 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies...

SONA.CN : 0.5000 (unch)
Sona Engages Clinical Trial Clinic for First-in-Human Early Feasibility Study of its THT Cancer Therapy

First Patients Expected to be Enrolled This MonthHalifax, Nova Scotia--(Newsfile Corp. - June 16, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") an oncology-focused life...

SONA.CN : 0.5000 (unch)
Sona Successfully Completes FDA-Required Toxicity Study

Halifax, Nova Scotia--(Newsfile Corp. - May 27, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce positive results from a required preclinical safety...

SONA.CN : 0.5000 (unch)
Sona Announces Successful Study Showing Absence of Endotoxins In Its Cancer Therapy Gold Nanorods Prior to First-in-human Clinical Trial

Halifax, Nova Scotia--(Newsfile Corp. - May 15, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to announce the successful completion of bacterial endotoxin testing...

SONA.CN : 0.5000 (unch)
BioVaxys and Sona Nanotech Enter Research Collaboration

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SONA) (OTC: SNANF) ("Sona") announce today...

BVAXF : 0.1498 (-3.91%)
BIOV.CN : 0.1900 (-9.52%)
SONA.CN : 0.5000 (unch)
SNANF : 0.3785 (+2.10%)
Sona Nanotech Announces Annual Options Grants

Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona") announces that it has granted 2,135,000 incentive stock options under the...

SONA.CN : 0.5000 (unch)
Sona Presents Additional Preclinical Data Demonstrating Repeated Ability Of Its Cancer Therapy To Inhibit Tumor Growth In Colorectal Cancer Model

Halifax, Nova Scotia--(Newsfile Corp. - March 19, 2025) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") is pleased to provide updated data confirming efficacy of its Targeted Hyperthermia...

SONA.CN : 0.5000 (unch)
Sona Nanotech Inc. CEO David Regan to Present at the Investor Summit Virtual on March 11

NEW YORK, NY / ACCESS Newswire / March 6, 2025 / David Regan, CEO of Sona Nanotech Inc. (OTCQB:SNANF)(CSE:SONA), will be presenting at this year's Investor Summit Virtual on March 11th at 11:30am ET.

SONA.CN : 0.5000 (unch)
SNANF : 0.3785 (+2.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use...

See More

Key Turning Points

3rd Resistance Point 0.5067
2nd Resistance Point 0.5033
1st Resistance Point 0.5017
Last Price 0.5000
1st Support Level 0.4967
2nd Support Level 0.4933
3rd Support Level 0.4917

See More

52-Week High 0.9100
Fibonacci 61.8% 0.6541
Fibonacci 50% 0.5750
Last Price 0.5000
Fibonacci 38.2% 0.4959
52-Week Low 0.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar